Milestone Pharmaceuticals Inc (NASDAQ:MIST) has a beta value of 0.97 and has seen 33.29 million shares traded in the last trading session. The company, currently valued at $46.95M, closed the last trade at $0.88 per share which meant it lost -$1.37 on the day or -60.89% during that session. The MIST stock price is -212.5% off its 52-week high price of $2.75 and -27.27% below the 52-week low of $1.12. If we look at the company’s 10-day average daily trading volume, we find that it stood at 7.26 million shares traded. The 3-month trading volume is 1.56 million shares.
The consensus among analysts is that Milestone Pharmaceuticals Inc (MIST) is Buy stock at the moment, with a recommendation rating of 1.40. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.19.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Sporting -60.89% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MIST stock price touched $0.88 or saw a rise of 62.71%. Year-to-date, Milestone Pharmaceuticals Inc shares have moved -62.71%, while the 5-day performance has seen it change -53.68%. Over the past 30 days, the shares of Milestone Pharmaceuticals Inc (NASDAQ:MIST) have changed -49.43%. Short interest in the company has seen 0.88 million shares shorted with days to cover at 0.62.
Wall Street analysts have a consensus price target for the stock at $10, which means that the shares’ value could jump 91.2% from current levels. The projected low price target is $10.0 while the price target rests at a high of $10.0. In that case, then, we find that the current price level is -1036.36% off the targeted high while a plunge would see the stock gain -1036.36% from current levels.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
The company’s shares have lost -41.72% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 28.21% over the past 5 years. Earnings growth for 2025 is a modest -50.75% while over the next 5 years, the company’s earnings are expected to decrease by -7.26%.
MIST Dividends
Milestone Pharmaceuticals Inc is expected to release its next earnings report on 2025-Mar-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
Insiders own 0.65% of the company shares, while shares held by institutions stand at 46.69% with a share float percentage of 47.00%. Investors are also buoyed by the number of investors in a company, with Milestone Pharmaceuticals Inc having a total of 53.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 4.97 million shares worth more than $6.56 million. As of 2024-06-30, BLACKROCK INC. held 7.5135% of shares outstanding.
The other major institutional holder is RTW INVESTMENTS, LP, with the holding of over 3.26 million shares as of 2024-06-30. The firm’s total holdings are worth over $4.3 million and represent 4.9211% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund and SPDR INDEX SHARES FUNDS-SPDR(R) S&P(R) International Small Cap ETF . As of Dec 31, 2024 , the former fund manager holds about 0.04% shares in the company for having 19.87 shares of worth $17487.0 while later fund manager owns 19.12 shares of worth $16822.0 as of Jan 31, 2025 , which makes it owner of about 0.04% of company’s outstanding stock.
